2023-01-012023-12-312023-12-31false10137968IPR Technology Limited2024-09-24iso4217:GBPxbrli:pure101379682023-01-01101379682023-12-31101379682023-01-012023-12-31101379682022-01-01101379682022-12-31101379682022-01-012022-12-3110137968bus:SmallEntities2023-01-012023-12-3110137968bus:AuditExempt-NoAccountantsReport2023-01-012023-12-3110137968bus:FullAccounts2023-01-012023-12-3110137968bus:PrivateLimitedCompanyLtd2023-01-012023-12-3110137968core:WithinOneYear2023-12-3110137968core:AfterOneYear2023-12-3110137968core:WithinOneYear2022-12-3110137968core:AfterOneYear2022-12-3110137968core:ShareCapital2023-12-3110137968core:SharePremium2023-12-3110137968core:RevaluationReserve2023-12-3110137968core:OtherReservesSubtotal2023-12-3110137968core:RetainedEarningsAccumulatedLosses2023-12-3110137968core:ShareCapital2022-12-3110137968core:SharePremium2022-12-3110137968core:RevaluationReserve2022-12-3110137968core:OtherReservesSubtotal2022-12-3110137968core:RetainedEarningsAccumulatedLosses2022-12-3110137968core:LandBuildings2023-12-3110137968core:PlantMachinery2023-12-3110137968core:Vehicles2023-12-3110137968core:FurnitureFittings2023-12-3110137968core:OfficeEquipment2023-12-3110137968core:NetGoodwill2023-12-3110137968core:IntangibleAssetsOtherThanGoodwill2023-12-3110137968core:ListedExchangeTraded2023-12-3110137968core:UnlistedNon-exchangeTraded2023-12-3110137968core:LandBuildings2022-12-3110137968core:PlantMachinery2022-12-3110137968core:Vehicles2022-12-3110137968core:FurnitureFittings2022-12-3110137968core:OfficeEquipment2022-12-3110137968core:NetGoodwill2022-12-3110137968core:IntangibleAssetsOtherThanGoodwill2022-12-3110137968core:ListedExchangeTraded2022-12-3110137968core:UnlistedNon-exchangeTraded2022-12-3110137968core:LandBuildings2023-01-012023-12-3110137968core:PlantMachinery2023-01-012023-12-3110137968core:Vehicles2023-01-012023-12-3110137968core:FurnitureFittings2023-01-012023-12-3110137968core:OfficeEquipment2023-01-012023-12-3110137968core:NetGoodwill2023-01-012023-12-3110137968core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3110137968core:ListedExchangeTraded2023-01-012023-12-3110137968core:UnlistedNon-exchangeTraded2023-01-012023-12-3110137968core:MoreThanFiveYears2023-01-012023-12-3110137968core:Non-currentFinancialInstruments2023-12-3110137968core:Non-currentFinancialInstruments2022-12-3110137968dpl:CostSales2023-01-012023-12-3110137968dpl:DistributionCosts2023-01-012023-12-3110137968core:LandBuildings2023-01-012023-12-3110137968core:PlantMachinery2023-01-012023-12-3110137968core:Vehicles2023-01-012023-12-3110137968core:FurnitureFittings2023-01-012023-12-3110137968core:OfficeEquipment2023-01-012023-12-3110137968dpl:AdministrativeExpenses2023-01-012023-12-3110137968core:NetGoodwill2023-01-012023-12-3110137968core:IntangibleAssetsOtherThanGoodwill2023-01-012023-12-3110137968dpl:GroupUndertakings2023-01-012023-12-3110137968dpl:ParticipatingInterests2023-01-012023-12-3110137968dpl:GroupUndertakingscore:ListedExchangeTraded2023-01-012023-12-3110137968core:ListedExchangeTraded2023-01-012023-12-3110137968dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-01-012023-12-3110137968core:UnlistedNon-exchangeTraded2023-01-012023-12-3110137968dpl:CostSales2022-01-012022-12-3110137968dpl:DistributionCosts2022-01-012022-12-3110137968core:LandBuildings2022-01-012022-12-3110137968core:PlantMachinery2022-01-012022-12-3110137968core:Vehicles2022-01-012022-12-3110137968core:FurnitureFittings2022-01-012022-12-3110137968core:OfficeEquipment2022-01-012022-12-3110137968dpl:AdministrativeExpenses2022-01-012022-12-3110137968core:NetGoodwill2022-01-012022-12-3110137968core:IntangibleAssetsOtherThanGoodwill2022-01-012022-12-3110137968dpl:GroupUndertakings2022-01-012022-12-3110137968dpl:ParticipatingInterests2022-01-012022-12-3110137968dpl:GroupUndertakingscore:ListedExchangeTraded2022-01-012022-12-3110137968core:ListedExchangeTraded2022-01-012022-12-3110137968dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2022-01-012022-12-3110137968core:UnlistedNon-exchangeTraded2022-01-012022-12-3110137968core:NetGoodwill2023-12-3110137968core:IntangibleAssetsOtherThanGoodwill2023-12-3110137968core:LandBuildings2023-12-3110137968core:PlantMachinery2023-12-3110137968core:Vehicles2023-12-3110137968core:FurnitureFittings2023-12-3110137968core:OfficeEquipment2023-12-3110137968core:AfterOneYear2023-12-3110137968core:WithinOneYear2023-12-3110137968core:ListedExchangeTraded2023-12-3110137968core:UnlistedNon-exchangeTraded2023-12-3110137968core:ShareCapital2023-12-3110137968core:SharePremium2023-12-3110137968core:RevaluationReserve2023-12-3110137968core:OtherReservesSubtotal2023-12-3110137968core:RetainedEarningsAccumulatedLosses2023-12-3110137968core:NetGoodwill2022-12-3110137968core:IntangibleAssetsOtherThanGoodwill2022-12-3110137968core:LandBuildings2022-12-3110137968core:PlantMachinery2022-12-3110137968core:Vehicles2022-12-3110137968core:FurnitureFittings2022-12-3110137968core:OfficeEquipment2022-12-3110137968core:AfterOneYear2022-12-3110137968core:WithinOneYear2022-12-3110137968core:ListedExchangeTraded2022-12-3110137968core:UnlistedNon-exchangeTraded2022-12-3110137968core:ShareCapital2022-12-3110137968core:SharePremium2022-12-3110137968core:RevaluationReserve2022-12-3110137968core:OtherReservesSubtotal2022-12-3110137968core:RetainedEarningsAccumulatedLosses2022-12-3110137968core:NetGoodwill2022-01-0110137968core:IntangibleAssetsOtherThanGoodwill2022-01-0110137968core:LandBuildings2022-01-0110137968core:PlantMachinery2022-01-0110137968core:Vehicles2022-01-0110137968core:FurnitureFittings2022-01-0110137968core:OfficeEquipment2022-01-0110137968core:AfterOneYear2022-01-0110137968core:WithinOneYear2022-01-0110137968core:ListedExchangeTraded2022-01-0110137968core:UnlistedNon-exchangeTraded2022-01-0110137968core:ShareCapital2022-01-0110137968core:SharePremium2022-01-0110137968core:RevaluationReserve2022-01-0110137968core:OtherReservesSubtotal2022-01-0110137968core:RetainedEarningsAccumulatedLosses2022-01-0110137968core:AfterOneYear2023-01-012023-12-3110137968core:WithinOneYear2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:CostValuation2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-01-012023-12-3110137968core:Non-currentFinancialInstrumentscore:CostValuation2023-12-3110137968core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2023-12-3110137968core:Non-currentFinancialInstrumentscore:CostValuation2022-12-3110137968core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2022-12-3110137968core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2022-12-3110137968core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2022-12-3110137968core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2022-12-3110137968core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2022-12-3110137968core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2022-12-3110137968core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2022-12-3110137968core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2022-12-3110137968bus:Director12023-01-012023-12-3110137968bus:Director22023-01-012023-12-31

IPR Technology Limited

Registered Number
10137968
(England and Wales)

Unaudited Financial Statements for the Year ended
31 December 2023

IPR Technology Limited
Company Information
for the year from 1 January 2023 to 31 December 2023

Directors

M Heal
C J Padfield

Registered Address

93-95 Gloucester Place
London
W1U 6JQ

Registered Number

10137968 (England and Wales)
IPR Technology Limited
Statement of Financial Position
31 December 2023

Notes

2023

2022

£

£

£

£

Current assets
Debtors3-21
Cash at bank and on hand18,20035,725
18,20035,746
Creditors amounts falling due within one year4(5,477)(15,661)
Net current assets (liabilities)12,72320,085
Total assets less current liabilities12,72320,085
Net assets12,72320,085
Capital and reserves
Called up share capital100100
Profit and loss account12,62319,985
Shareholders' funds12,72320,085
The financial statements were approved and authorised for issue by the Board of Directors on 24 September 2024, and are signed on its behalf by:
C J Padfield
Director
Registered Company No. 10137968
IPR Technology Limited
Notes to the Financial Statements
for the year ended 31 December 2023

1.Accounting policies
Statutory information
IPR Technology Limited is a private company, limited by shares, registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.
Basis of preparation
The financial statements have been prepared under the historical cost convention.
Functional and presentation currency
The financial statements are presented in pound sterling (£), which is the company’s functional currency, and figures are rounded to the nearest whole pound.
Going concern
The financial statements have been prepared on the going concern basis. The company made a profit during the year and the directors believe that the company has sufficient financial resources to meet its obligations as they become due, and that the company can continue in operational existence for a period of at least 12 months from the statement of financial position date. Consequently, the directors have concluded that it is appropriate to prepare the annual financial statements on a going concern basis.
Judgements and key sources of estimation uncertainty
There have been no significant judgements or estimates applied to the numbers contained within these financial statements.
Turnover policy
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value-added tax, and other sales taxes.
Revenue from rendering of services
Revenue from the rendering of services such as SAAS subscriptions is recognised by reference to the stage of completion of the transaction providing that; the amount of revenue associated with the transaction can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company, the stage of completion of the transaction can be measured reliably and the costs incurred or to be incurred in respect of completing the transaction can be measured reliably.
Foreign currency translation
Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each reporting period end foreign currency monetary items are translated using the closing rate. Non monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined. Foreign exchange gains and losses resulting from the settlement of transactions and from the translation at the period-end exchange rates of monetary assets and liabilities denominated in foreign currencies are recognised in the income statement.
Current taxation
Taxation for the year comprises current tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
Cash and cash equivalents
Cash and cash equivalents comprise cash on hand and demand deposits and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk to changes in value.
Trade and other creditors
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
Financial instruments
The Company has chosen to adopt Sections 11 and 12 of FRS 102 in respect of financial instruments. The Company only enters into basic financial instruments transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in non puttable ordinary shares. Debt instruments (other than those wholly repayable or receivable within one year), including loans and other accounts receivable and payable, are initially measured at present value of the future cash flows and subsequently at amortised cost using the effective interest method. Debt instruments that are payable or receivable within one year, typically trade debtors and creditors, are measured, initially and subsequently,at the undiscounted amount of the cash or other consideration expected to be paid or received. However, if the arrangements of a short term instrument constitute a financing transaction, like the payment of a trade debt deferred beyond normal business terms or financed at a rate of interest that is not a market rate or in case of an out right short term loan not at market rate, the financial asset or liability is measured, initially,at the present value of the future cash flow discounted at a market rate of interest for a similar debt instrument and subsequently at amortised cost. Financial assets and liabilities are offset and the net amount reported in the Statement of Financial Position when there is an enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
2.Average number of employees

20232022
Average number of employees during the year00
3.Debtors: amounts due within one year

2023

2022

££
Other debtors-21
Total-21
4.Creditors: amounts due within one year

2023

2022

££
Trade creditors / trade payables1,140-
Taxation and social security6642,349
Accrued liabilities and deferred income3,67313,312
Total5,47715,661